Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bug

Showing results (171-180 of 319) with videos related to

Pageof 32
Sort By:
British Journal of Haematology|June 9, 2018
Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemiaOliver G Ottmann, Carsten Müller-Tidow, Alwin Krämer, et al.
Haematologica|May 25, 2010
IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosisFelicitas Thol, Eva M Weissinger, Jürgen Krauter, et al.
British Journal of Haematology|November 20, 2018
A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemiaHartmut Döhner, Carsten Müller-Tidow, Michael Lübbert, et al.
Leukemia|July 29, 2017
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)G Bug, A Burchert, E-M Wagner, et al.
American Journal of Hematology|May 14, 2024
Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantationNico Gagelmann, Claudia Schuh, Sarah Flossdorf, et al.
Annals of Hematology|August 28, 2013
Long-term results of a prospective randomized trial evaluating G-CSF priming in intensive induction chemotherapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemiaGesine Bug, Steffen Koschmieder, Juergen Krauter, et al.
Annals of Hematology|November 20, 2017
Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study GroupThomas Schroeder, Christina Rautenberg, William Krüger, et al.
Plos One|July 20, 2018
Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survivalSebastian Scheich, Rosalie Koenig, Anne C Wilke, et al.
Nature Cell Biology|August 9, 2011
Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutationsDanilo Ritz, Maja Vuk, Philipp Kirchner, et al.
Cancer|September 30, 2017
Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemiaSebastian Scheich, Sarah Lindner, Rosalie Koenig, et al.
Pageof 32

Showing results (171-180 of 319) with videos related to

Sort By:
Pageof 32
British Journal of Haematology|June 9, 2018
Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemiaOliver G Ottmann, Carsten Müller-Tidow, Alwin Krämer, et al.
Haematologica|May 25, 2010
IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosisFelicitas Thol, Eva M Weissinger, Jürgen Krauter, et al.
British Journal of Haematology|November 20, 2018
A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemiaHartmut Döhner, Carsten Müller-Tidow, Michael Lübbert, et al.
Leukemia|July 29, 2017
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)G Bug, A Burchert, E-M Wagner, et al.
American Journal of Hematology|May 14, 2024
Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantationNico Gagelmann, Claudia Schuh, Sarah Flossdorf, et al.
Annals of Hematology|August 28, 2013
Long-term results of a prospective randomized trial evaluating G-CSF priming in intensive induction chemotherapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemiaGesine Bug, Steffen Koschmieder, Juergen Krauter, et al.
Annals of Hematology|November 20, 2017
Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study GroupThomas Schroeder, Christina Rautenberg, William Krüger, et al.
Plos One|July 20, 2018
Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survivalSebastian Scheich, Rosalie Koenig, Anne C Wilke, et al.
Nature Cell Biology|August 9, 2011
Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutationsDanilo Ritz, Maja Vuk, Philipp Kirchner, et al.
Cancer|September 30, 2017
Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemiaSebastian Scheich, Sarah Lindner, Rosalie Koenig, et al.
Pageof 32